Refractory High Risk Myelodysplastic Syndrome
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00987 | Cytarabine | 1 | Completed | 1 |
| DB00987 | Cytarabine | 1 | Recruiting | 1 |
| DB00694 | Daunorubicin | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Completed | 1 |
| DB09053 | Ibrutinib | 1 | Completed | 1 |
| DB00480 | Lenalidomide | 1 | Completed | 1 |
| DB12008 | Prexasertib | 1 | Completed | 1 |
| DB15013 | TAK-243 | 1 | Not Yet Recruiting | 1 |
| DB00242 | Cladribine | 1 / 2 | Completed | 1 |
| DB00242 | Cladribine | 1 / 2 | Recruiting | 1 |
| DB00987 | Cytarabine | 1 / 2 | Completed | 1 |
| DB00987 | Cytarabine | 1 / 2 | Recruiting | 1 |
| DB01262 | Decitabine | 1 / 2 | Completed | 1 |
| DB00099 | Filgrastim | 1 / 2 | Completed | 1 |
| DB01177 | Idarubicin | 1 / 2 | Recruiting | 1 |
| DB01204 | Mitoxantrone | 1 / 2 | Completed | 1 |
| DB12874 | Quizartinib | 1 / 2 | Recruiting | 1 |
| DB00928 | Azacitidine | 2 | Recruiting | 1 |
| DB13874 | Enasidenib | 2 | Recruiting | 1 |